Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

Cardiology Clinics

Volumn 35, Issue 1, 2017, Pages 99-115

  Vedanthan, Rajesh ^a   Bernabe Ortiz, Antonio ^b   Herasme, Omarys I ^a   Joshi, Rohina ^c   Lopez Jaramillo, Patricio ^d   Thrift, Amanda G ^e   Webster, Jacqui ^c   Webster, Ruth ^c   Yeates, Karen ^f   Gyamfi, Joyce ^g   Ieremia, Merina ^h   Johnson, Claire ^c   Kamano, Jemima H ⁱ   Lazo Porras, Maria ^b   Limbani, Felix ^j   Liu, Peter ^k   McCready, Tara ^l   Miranda, J Jaime ^b   Mohan, Sailesh ^m   Ogedegbe, Olugbenga ^g   Oldenburg, Brian ⁿ   Ovbiagele, Bruce ^o   Owolabi, Mayowa ^p   Peiris, David ^c   Ponce Lucero, Vilarmina ^b   Praveen, Devarsetty ^q   Pillay, Arti ^r   Schwalm, Jon David ^l   Tobe, Sheldon W ^s   Trieu, Kathy ^c   Yusoff, Khalid ^t   Fuster, Valentin ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Research Institute FOSCAL   (Colombia)

^e MONASH UNIVERSITY   (Australia)

^f QUEEN S UNIVERSITY   (Canada)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Samoan Ministry of Health   (Samoa)

ⁱ MOI UNIVERSITY   (Kenya)

^j UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^k UNIVERSITY OF OTTAWA   (Canada)

^l MCMASTER UNIVERSITY   (Canada)

^m PUBLIC HEALTH FOUNDATION OF INDIA   (India)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

^o MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^p UNIVERSITY OF IBADAN   (Nigeria)

^q GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^r FIJI NATIONAL UNIVERSITY   (Fiji)

^s UNIVERSITY OF TORONTO   (Canada)

^t UNIVERSITI TEKNOLOGI MARA   (Malaysia)

more..

Author keywords

Community engagement; Hypertension; Low and middle income countries; mHealth; Polypill; Salt reduction; Salt substitution; Task redistribution

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR RISK; DRUG COMBINATION; ELEVATED BLOOD PRESSURE; EXPERIMENTAL THERAPY; FIXED DOSE COMBINATION; HEALTH AUXILIARY; HEALTH CARE DISTRIBUTION; HUMAN; HYPERTENSION; LOW INCOME COUNTRY; META ANALYSIS (TOPIC); MIDDLE INCOME COUNTRY; MOBILE HEALTH; MOBILE PHONE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SODIUM RESTRICTION; SUBSTITUTION THERAPY; BLOOD PRESSURE; DEVELOPING COUNTRY; INCIDENCE; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TELEMEDICINE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DEVELOPING COUNTRIES; HUMANS; HYPERTENSION; INCIDENCE; RISK FACTORS; TELEMEDICINE;

EID: 84996993001     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2016.08.010     Document Type: Review

References (79)

1. 1 Lim, S.S., Vos, T., Flaxman, A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:9859 (2012), 2224–2260.
2. 2 Lewington, S., Clarke, R., Qizilbash, N., et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:9349 (2002), 1903–1913.
3. 3 Chow, C.K., Teo, K.K., Rangarajan, S., et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310:9 (2013), 959–968.
4. 4 Global Alliance for Chronic Diseases. Available at: http://www.gacd.org/about. Accessed September 26, 2016.
5. 5 W Tobe, S., The Global Alliance for Chronic Diseases Hypertension Research Teams With the World Hypertension League, The Global Alliance for Chronic Diseases supports 15 major studies in hypertension prevention and control in low- and middle-income countries. J Clin Hypertens (Greenwich) 18:7 (2016), 600–605.
6. 6 Khatib, R., Schwalm, J.D., Yusuf, S., et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One, 9(1), 2014, e84238.
7. 7 Maimaris, W., Paty, J., Perel, P., et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PloS Med, 10(7), 2013, e1001490.
8. 8 Digiacomo, M., Abbott, P., Davison, J., et al. Facilitating uptake of aboriginal adult health checks through community engagement and health promotion. Qual Prim Care 18:1 (2010), 57–64.
9. 9 National Institute for Health and Care Excellence, Community engagement to improve health. 2014, National Institute for Health and Care Excellence, London Available at: https://www.nice.org.uk/guidance/lgb16/resources/community-engagement-to-improve-health-60521149786309 Accessed May 14, 2016.
10. 10 Rosato, M., Laverack, G., Grabman, L.H., et al. Community participation: lessons for maternal, newborn, and child health. Lancet 372:9642 (2008), 962–971.
11. 11 Joint United Nations Programme on HIV/AIDS (UNAIDS), Promising practices in community engagement for elimination of new HIV infections among children by 2015 and keeping their mothers alive. 2012, UNAIDS, Geneva (Switzerland) Available at: http://www.unaids.org/sites/default/files/media_asset/20120628_JC2281_PromisingPracticesCommunityEngagements_en_0.pdf 15 May 2016.
12. 12 Rifkin, S.B., Examining the links between community participation and health outcomes: a review of the literature. Health Policy Plan 29:Suppl 2 (2014), ii98–ii106.
13. 13 Marston, C., Renedo, A., McGowan, C.R., et al. Effects of community participation on improving uptake of skilled care for maternal and newborn health: a systematic review. PLoS One, 8(2), 2013, e55012.
14. 14 Vedanthan, R., Kamano, J.H., Naanyu, V., et al. Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Trials, 15(1), 2014, 143.
15. 15 Naanyu, V., Vedanthan, R., Kamano, J.H., et al. Barriers influencing linkage to hypertension care in Kenya: qualitative analysis from the LARK hypertension study. J Gen Intern Med 31:3 (2016), 304–314.
16. 16 Maar, M., Yeates, K., Barron, M., et al. I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions. Implement Sci, 10, 2015, 64.
17. 17 Bradley, H.A., Puoane, T., Prevention of hypertension and diabetes in an urban setting in South Africa: participatory action research with community health workers. Ethn Dis 17:1 (2007), 49–54.
18. 18 Balcazar, H.G., Byrd, T.L., Ortiz, M., et al. A randomized community intervention to improve hypertension control among Mexican Americans: using the promotoras de salud community outreach model. J Health Care Poor Underserved 20:4 (2009), 1079–1094.
19. 19 He, F.J., Li, J., Macgregor, G.A., Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ, 346, 2013, f1325.
20. 20 Aburto, N.J., Ziolkovska, A., Hooper, L., et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ, 346, 2013, f1326.
21. 21 Reducing salt intake in populations: report of a WHO forum and technical meeting, 2007, World Health Organization, Geneva (Switzerland).
22. 22 Guideline: sodium intake for adults and children, 2012, World Health Organization, Geneva (Switzerland).
23. 23 World Health Organization (WHO). Monitoring framework and targets for the prevention and control of NCDs. Revised WHO discussion paper on the development of a comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of NCDs. 2012. Available at: http://www.who.int/nmh/events/2012/discussion_paper3.pdf. Accessed February 17, 2013.
24. 24 Trieu, K., Neal, B., Hawkes, C., et al. Salt reduction initiatives around the world – a systematic review of progress towards the global target. PLoS One, 10(7), 2015, e0130247.
25. 25 Webster, J., Su'a, S.A., Ieremia, M., et al. Salt intakes, knowledge, and behavior in Samoa: monitoring salt-consumption patterns through the World Health Organization's surveillance of noncommunicable disease risk factors (STEPS). J Clin Hypertens (Greenwich) 18:9 (2016), 884–891.
26. 26 The World Health Organization, Creating an enabling environment for population-based salt reduction strategies. 2011, World Health Organization, Geneva (Switzerland).
27. 27 Webster, J., Snowdon, W., Moodie, M., et al. Cost-effectiveness of reducing salt intake in the Pacific Islands: protocol for a before and after intervention study. BMC Public Health, 14, 2014, 107.
28. 28 Dunford, E., Trevena, H., Goodsell, C., et al. FoodSwitch: a mobile phone app to enable consumers to make healthier food choices and crowdsourcing of national food composition data. JMIR Mhealth Uhealth, 2(3), 2014, e37.
29. 29 He, F.J., Wu, Y., Feng, X.X., et al. School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial. BMJ, 350, 2015, h770.
30. 30 Peng, Y.G., Li, W., Wen, X.X., et al. Effects of salt substitutes on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr 100:6 (2014), 1448–1454.
31. 31 Bernabe-Ortiz, A., Diez-Canseco, F., Gilman, R.H., et al. Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru. Trials, 15, 2014, 93.
32. 32 Saavedra-Garcia, L., Bernabe-Ortiz, A., Gilman, R.H., et al. Applying the triangle taste test to assess differences between low sodium salts and common salt: evidence from Peru. PLoS One, 10(7), 2015, e0134700.
33. 33 Salt substitution, A low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens 25:10 (2007), 2011–2018.
34. 34 Zhou, X., Liu, J.X., Shi, R., et al. Compound ion salt, a novel low-sodium salt substitute: from animal study to community-based population trial. Am J Hypertens 22:9 (2009), 934–942.
35. 35 Zhao, X., Yin, X., Li, X., et al. Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial. PLoS One, 9(10), 2014, e110131.
36. 36 World Health Organization (WHO), World health report 2006: working together for health. 2006, WHO, Geneva (Switzerland).
37. 37 Ministry of Health and Family Welfare, Rural health statistics bulletin, March 2010. 2010, Government of India, New Delhi (India).
38. 38 World Health Organization (WHO), Density of physicians (total number per 1000 population, latest available year). 2016, Global Health Observatory Data, Geneva (Switzerland) Available at: http://www.who.int/gho/health_workforce/physicians_density_text/en/ Accessed May 13,2016.
39. 39 Deller, B., Tripathi, V., Stender, S., et al. Task shifting in maternal and newborn health care: key components from policy to implementation. Int J Gynecol Obstet 130:Suppl 2 (2015), S25–S31.
40. 40 Dawson, A.J., Buchan, J., Duffield, C., et al. Task shifting and sharing in maternal and reproductive health in low-income countries: a narrative synthesis of current evidence. Health Policy Plan 29:3 (2014), 396–408.
41. 41 World Health Organization (WHO). Task shifting to tackle health worker shortages. Geneva (Switzerland): WHO Press; 2007.
42. 42 Lekoubou, A., Awah, P., Fezeu, L., et al. Hypertension, diabetes mellitus and task shifting and their management in sub-Saharan Africa. Int J Environ Res Public Health 7 (2010), 353–363.
43. 43 60th WMA general assembly. WMA resolution on task shifting from the medical profession, 2009, World Medical Association, New Delhi.
44. 44 Joshi, R., Alim, M., Kengne, A.P., et al. Task shifting for non-communicable disease management in low and middle income countries ? A systematic review. PLoS One, 9(8), 2014, e103754.
45. 45 Ogedegbe, G., Gyamfi, J., Plange-Rhule, J., et al. Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: a systematic review of randomised controlled trials. BMJ Open, 4(10), 2014, e005983.
46. 46 Gaziano, T.A., Abrahams-Gessel, S., Denman, C.A., et al. An assessment of community health workers' ability to screen for cardiovascular disease risk with a simple, non-invasive risk assessment instrument in Bangladesh, Guatemala, Mexico, and South Africa: an observational study. Lancet Glob Health 3:9 (2015), e556–e563.
47. 47 Akinyemi, R.O., Owolabi, M.O., Adebayo, P.B., et al. Task-shifting training improves stroke knowledge among Nigerian non-neurologist health workers. J Neurol Sci 359:1–2 (2015), 112–116.
48. 48 Joshi, R., Chow, C., Raju, P.K., et al. The rural Andhra Pradesh cardiovascular prevention study. J Am Coll Cardiol 59:13 (2012), 1188–1196.
49. 49 Kar, S.S., Thakur, J.S., Jain, S., et al. Cardiovascular disease risk management in a primary health care setting of north India. Indian Heart J 60:1 (2008), 19–25.
50. 50 Jafar, T.H., Islam, M., Hatcher, J., et al. Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial. BMJ, 340, 2010, c2641.
51. 51 Xavier, D., Gupta, R., Kamath, D., et al. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial. Lancet Diabetes Endocrinol 4:3 (2016), 244–253.
52. 52 Gaziano, T., Abrahams-Gessel, S., Surka, S., et al. Cardiovascular disease screening by community health workers can be cost-effective in low-resource countries. Health Aff (Millwood) 34:9 (2015), 1538–1545.
53. 53 Buttorff, C., Hock, R.S., Weiss, H.A., et al. Economic evaluation of a task-shifting intervention for common mental disorders in India. Bull World Health Organ 90 (2012), 813–821.
54. 54 Thorogood, M., Goudge, J., Bertram, M., et al. The Nkateko health service trial to improve hypertension management in rural South Africa: study protocol for a randomised controlled trial. Trials, 15, 2014, 435.
55. 55 Ogedegbe, G., Plange-Rhule, J., Gyamfi, J., et al. A cluster-randomized trial of task shifting and blood pressure control in Ghana: study protocol. Implement Sci, 9, 2014, 73.
56. 56 Praveen, D., Patel, A., McMahon, S., et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Sci, 8, 2013, 137.
57. 57 Praveen, D., Patel, A., Raghu, A., et al. SMARTHealth India: development and field evaluation of a mobile clinical decision support system for cardiovascular diseases in rural India. JMIR Mhealth Uhealth, 2(4), 2014, e54.
58. 58 Piette, J.D., List, J., Rana, G.K., et al. Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation 132:21 (2015), 2012–2027.
59. 59 Peiris, D., Praveen, D., Johnson, C., et al. Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review. J Cardiovasc Transl Res 7:8 (2014), 677–691.
60. 60 Bloomfield, G.S., Vedanthan, R., Vasudevan, L., et al. Mobile health for non-communicable diseases in Sub-Saharan Africa: a systematic review of the literature and strategic framework for research. Global Health, 10, 2014, 49.
61. 61 Beratarrechea, A., Lee, A.G., Willner, J.M., et al. The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. Telemed J E Health 20:1 (2014), 75–82.
62. 62 Okoro, E., Sholagberu, H., Kolo, P., Mobile phone ownership among Nigerians with diabetes. Afr Health Sci 10:2 (2010), 183–186.
63. 63 Owolabi, M.O., Akinyemi, R.O., Gebregziabher, M., et al. Randomized controlled trial of a multipronged intervention to improve blood pressure control among stroke survivors in Nigeria. Int J Stroke 9:8 (2014), 1109–1116.
64. 64 Cushman, W.C., Ford, C.E., Einhorn, P.T., et al. Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 10:10 (2008), 751–760.
65. 65 Johnston, A., Stafylas, P., Stergiou, G.S., Effectiveness, safety and cost of drug substitution in hypertension. Br J Clin Pharmacol 70:3 (2010), 320–334.
66. 66 Shaw, E., Anderson, J.G., Maloney, M., et al. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm 30:3 (1995), 201–203.
67. 67 Faria, C., Wenzel, M., Lee, K.W., et al. A narrative review of clinical inertia: focus on hypertension. J Am Soc Hypertens 3:4 (2009), 267–276.
68. 68 Okonofua, E.C., Simpson, K.N., Jesri, A., et al. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 47:3 (2006), 345–351.
69. 69 Brown, M.J., McInnes, G.T., Papst, C.C., et al. Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. Lancet 377:9762 (2011), 312–320.
70. 70 Feldman, R.D., Zou, G.Y., Vandervoort, M.K., et al. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 53:4 (2009), 646–653.
71. 71 Gupta, A.K., Arshad, S., Poulter, N.R., Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 55:2 (2010), 399–407.
72. 72 Webster, R., Patel, A., Selak, V., et al. Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: a prospective, individual patient data meta-analysis of 3140 patients in six countries. Int J Cardiol 205 (2016), 147–156.
73. 73 Castellano, J.M., Sanz, G., Penalvo, J.L., et al. A polypill strategy to improve adherence: results from focus (Fixed-dose combination drug for secondary cardiovascular prevention) project. J Am Coll Cardiol 64:20 (2014), 2071–2082.
74. 74 Lonn, E.M., Bosch, J., López-Jaramillo, P., et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 374:21 (2016), 2009–2020.
75. 75 Yusuf, S., Lonn, E., Pais, P., et al. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med 374:21 (2016), 2032–2043.
76. 76 Salam, A., Webster, R., Singh, K., et al. TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): study protocol. Am Heart J 167:2 (2014), 127–132.
77. 77 Thom, S., Poulter, N., Field, J., et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the umpire randomized clinical trial. JAMA 310:9 (2013), 918–929.
78. 78 Patel, A., Cass, A., Peiris, D., et al. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. Eur J Prev Cardiol 22:7 (2015), 920–930.
79. 79 Selak, V., Elley, C.R., Bullen, C., et al. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ, 348, 2014, g3318.